Blood-based biomarkers for Alzheimer's disease diagnosis and progression: an overview

A Varesi, A Carrara, VG Pires, V Floris, E Pierella… - Cells, 2022‏ - mdpi.com
Alzheimer's Disease (AD) is a progressive neurodegenerative disease characterized by
amyloid-β (Aβ) plaque deposition and neurofibrillary tangle accumulation in the brain …

Schizophrenia: a disorder of broken brain bioenergetics

ND Henkel, X Wu, SM O'Donovan, EA Devine… - Molecular …, 2022‏ - nature.com
A substantial and diverse body of literature suggests that the pathophysiology of
schizophrenia is related to deficits of bioenergetic function. While antipsychotics are an …

The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice

P Zheng, B Zeng, M Liu, J Chen, J Pan, Y Han… - Science …, 2019‏ - science.org
Schizophrenia (SCZ) is a devastating mental disorder with poorly defined underlying
molecular mechanisms. The gut microbiome can modulate brain function and behaviors …

[HTML][HTML] Metabolomics for the masses: The future of metabolomics in a personalized world

DK Trivedi, KA Hollywood, R Goodacre - New horizons in translational …, 2017‏ - Elsevier
Current clinical practices focus on a small number of biochemical directly related to the
pathophysiology with patients and thus only describe a very limited metabolome of a patient …

Inflammation and the two-hit hypothesis of schizophrenia

KA Feigenson, AW Kusnecov, SM Silverstein - … & Biobehavioral Reviews, 2014‏ - Elsevier
The high societal and individual cost of schizophrenia necessitates finding better, more
effective treatment, diagnosis, and prevention strategies. One of the obstacles in this …

A systematic review of metabolite biomarkers of schizophrenia

J Davison, A O'Gorman, L Brennan, DR Cotter - Schizophrenia research, 2018‏ - Elsevier
Current diagnosis of schizophrenia relies exclusively on the potentially subjective
interpretation of clinical symptoms and social functioning as more objective biological …

Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction

F Guan, T Ni, W Zhu, LK Williams, LB Cui, M Li… - Molecular …, 2022‏ - nature.com
Schizophrenia (SCZ) is a debilitating neuropsychiatric disorder with high heritability and
complex inheritance. In the past decade, successful identification of numerous susceptibility …

Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders

J Yang, B Yan, B Zhao, Y Fan, X He, L Yang… - Schizophrenia …, 2020‏ - academic.oup.com
Psychiatric disorders are the leading cause of disability worldwide while the pathogenesis
remains unclear. Genome-wide association studies (GWASs) have made great …

[HTML][HTML] Identification and validation of urinary metabolite biomarkers for major depressive disorder

P Zheng, Y Wang, L Chen, D Yang, H Meng… - Molecular & cellular …, 2013‏ - Elsevier
Major depressive disorder (MDD) is a widespread and debilitating mental disorder.
However, there are no biomarkers available to aid in the diagnosis of this disorder. In this …

Impaired membrane lipid homeostasis in schizophrenia

M Li, Y Gao, D Wang, X Hu, J Jiang, Y Qing… - Schizophrenia …, 2022‏ - academic.oup.com
Abstract Background and Hypothesis Multiple lines of clinical, biochemical, and genetic
evidence suggest that disturbances of membrane lipids and their metabolism are probably …